These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 17356254

  • 1. Hepatitis C in chronic kidney disease: predialysis patients present more severe histological liver injury than hemodialysis patients?
    Lemos LB, Perez RM, Lemos MM, Lanzoni VP, Draibe SA, Silva IS, Silva AE, Ferraz ML.
    Am J Nephrol; 2007; 27(2):191-6. PubMed ID: 17356254
    [Abstract] [Full Text] [Related]

  • 2. Hepatitis C among predialysis patients: prevalence and characteristics in a large cohort of patients.
    Lemos LB, Perez RM, Lemos MM, Draibe SA, Silva IS, Silva AE, Ferraz ML.
    Nephron Clin Pract; 2008; 108(2):c135-40. PubMed ID: 18230916
    [Abstract] [Full Text] [Related]

  • 3. Lack of impact of hepatitis C virus coinfection in end-stage renal disease patients with hepatitis B virus infection.
    Moutinho RS, Perez RM, Pace FH, Ferreira AS, Cendoroglo M, Medina-Pestana JO, Lanzoni VP, Silva AE, Ferraz ML.
    Transplant Proc; 2005 Jun; 37(5):2080-2. PubMed ID: 15964344
    [Abstract] [Full Text] [Related]

  • 4. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation.
    Sterling RK, Sanyal AJ, Luketic VA, Stravitz RT, King AL, Post AB, Mills AS, Contos MJ, Shiffman ML.
    Am J Gastroenterol; 1999 Dec; 94(12):3576-82. PubMed ID: 10606322
    [Abstract] [Full Text] [Related]

  • 5. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
    Hissar SS, Kumar M, Tyagi P, Goyal A, Suneetha PV, Agarwal S, Rastogi A, Sakhuja P, Sarin SK.
    J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
    [Abstract] [Full Text] [Related]

  • 6. Clinical and laboratory characteristics of acute hepatitis C in patients with end-stage renal disease on hemodialysis.
    Lemos LB, Perez RM, Matos CA, Silva IS, Silva AE, Ferraz ML.
    J Clin Gastroenterol; 2008 Feb; 42(2):208-11. PubMed ID: 18209594
    [Abstract] [Full Text] [Related]

  • 7. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
    Stránský J, Ryzlová M, Striteský J, Horák J.
    Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
    [Abstract] [Full Text] [Related]

  • 8. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity.
    Mathurin P, Moussalli J, Cadranel JF, Thibault V, Charlotte F, Dumouchel P, Cazier A, Huraux JM, Devergie B, Vidaud M, Opolon P, Poynard T.
    Hepatology; 1998 Mar; 27(3):868-72. PubMed ID: 9500720
    [Abstract] [Full Text] [Related]

  • 9. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
    Hsieh MY, Dai CY, Lee LP, Huang JF, Tsai WC, Hou NJ, Lin ZY, Chen SC, Wang LY, Chang WY, Chuang WL, Yu ML.
    J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
    [Abstract] [Full Text] [Related]

  • 10. Factors associated with the progression of hepatic fibrosis in end-stage kidney disease patients with hepatitis C virus infection.
    Becker VR, Badiani RG, Lemos LB, Perez RM, Medina-Pestana JO, Lanzoni VP, Ferreira AP, Silva AE, Ferraz ML.
    Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1395-9. PubMed ID: 19525852
    [Abstract] [Full Text] [Related]

  • 11. Clinicopathological features of hepatitis C virus infection in dialysis and renal transplantation.
    Töz H, Ok E, Yilmaz F, Akarca US, Erensoy S, Zeytinoğlu A, Ozkahya M, Karasu Z, Yüce G, Başçi A.
    J Nephrol; 2002 Dec; 15(3):308-12. PubMed ID: 12116989
    [Abstract] [Full Text] [Related]

  • 12. Does end-stage kidney failure influence hepatitis C progression in hemodialysis patients?
    Luzar B, Ferlan-Marolt V, Brinovec V, Lesnicar G, Klopcic U, Poljak M.
    Hepatogastroenterology; 2003 Dec; 50(49):157-60. PubMed ID: 12630013
    [Abstract] [Full Text] [Related]

  • 13. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
    Sanai FM, Benmousa A, Al-Hussaini H, Ashraf S, Alhafi O, Abdo AA, Alameri HF, Akbar HO, Bzeizi KI.
    Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
    [Abstract] [Full Text] [Related]

  • 14. Hepatitis C, HCV genotypes and hepatic siderosis in patients with chronic renal failure on haemodialysis in Brazil.
    de Paula Farah K, Carmo RA, de Figueiredo Antunes CM, Serufo JC, Nobre Júnior VA, Fonseca de Castro LP, Leite VH, Silva RA, Alvares MC, Corrêa GO, Busek SC, Lambertucci JR.
    Nephrol Dial Transplant; 2007 Jul; 22(7):2027-31. PubMed ID: 17309883
    [Abstract] [Full Text] [Related]

  • 15. Investigation of possible clinical and laboratory predictors of liver fibrosis in hemodialysis patients infected with hepatitis C virus.
    Boyacioğlu S, Gür G, Yilmaz U, Korkmaz M, Demirhan B, Bilezikçi B, Ozdemir N.
    Transplant Proc; 2004 Jul; 36(1):50-2. PubMed ID: 15013298
    [Abstract] [Full Text] [Related]

  • 16. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L, Caspary WF, Chapman RW, Dietrich CF, Sarrazin C, Braden B.
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [Abstract] [Full Text] [Related]

  • 17. Clinical presentation of chronic hepatitis C in patients with end-stage renal disease and on hemodialysis versus those with normal renal function.
    Hu KQ, Lee SM, Hu SX, Xia VW, Hillebrand DJ, Kyulo NL.
    Am J Gastroenterol; 2005 Sep; 100(9):2010-8. PubMed ID: 16128946
    [Abstract] [Full Text] [Related]

  • 18. Effect of anti-HCV positivity on markers of malnutrition and inflammation in hemodialysis patients.
    Zumrutdal A, Ozer B, Singan M, Micozkadioglu H, Sezer S, Ozdemir FN, Haberal M.
    Ren Fail; 2007 Sep; 29(1):85-90. PubMed ID: 17365915
    [Abstract] [Full Text] [Related]

  • 19. Comparative study between occult hepatitis C virus infection and chronic hepatitis C.
    Pardo M, López-Alcorocho JM, Rodríguez-Iñigo E, Castillo I, Carreño V.
    J Viral Hepat; 2007 Jan; 14(1):36-40. PubMed ID: 17212642
    [Abstract] [Full Text] [Related]

  • 20. HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C.
    Patel K, Norris S, Lebeck L, Feng A, Clare M, Pianko S, Portmann B, Blatt LM, Koziol J, Conrad A, McHutchison JG.
    Hepatology; 2006 Feb; 43(2):241-9. PubMed ID: 16440356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.